Details for 2023188938
Up to date per 02.04.2026
Actions
Details for 2023188938
Granted/Registered
European Patent
06.12.2023 A
19.11.2025 B1
30.12.2015
US
201562272890 P
26.02.2016
US
201662300479 P
30.03.2016
US
201662315412 P
30.09.2016
US
201662402454 P
01.12.2016
US
201662428867 P
08.12.2016
US
201662431791 P
A61K 38/47 20060101AFI20250108BHEP
Owner
Amicus Therapeutics, Inc.3675 Market Street Philadelphia, PA 19104US
Representative
No representatives present
Inventor
Do, Hung V. Philadelphia, 19104US
Khanna, Richie Philadelphia, 19104US
Gotschall, Russell Philadelphia, 19104US
Information about Fees